NCT00782574View on ClinicalTrials.gov

Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

November 12, 2008

Primary Completion Date

February 1, 2012

Study Completion Date

December 7, 2023

Conditions

Advanced Solid Tumors

Interventions

DRUG

AZD2281

Tablets Oral BID

DRUG

Cisplatin

IV every 3 weeks

Trial Locations (3)

8035

Research Site, Barcelona

02114

Research Site, Boston

02215

Research Site, Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY